1170 companies

JD.com

Market Cap: US$47.1b

Operates as a supply chain-based technology and service provider in the People’s Republic of China.

JD

US$32.70

7D

0.4%

1Y

25.3%

Summit Therapeutics

Market Cap: US$15.8b

A biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies.

SMMT

US$21.20

7D

1.3%

1Y

181.2%

QXO

Market Cap: US$14.4b

Distributes roofing, waterproofing, and other building products in the United States.

QXO

US$21.18

7D

-9.9%

1Y

-67.8%

Moderna

Market Cap: US$10.7b

A biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.

MRNA

US$28.69

7D

7.1%

1Y

-75.5%

BioMarin Pharmaceutical

Market Cap: US$10.5b

A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

BMRN

US$56.19

7D

2.7%

1Y

-31.7%

Aurora Innovation

Market Cap: US$9.3b

Operates as a self-driving technology company in the United States.

AUR

US$5.05

7D

-7.3%

1Y

76.0%

VinFast Auto

Market Cap: US$8.3b

Engages in the design and manufacture of electric vehicles (EV), e-scooters, and e-buses in Vietnam, Canada, and the United States.

VFS

US$3.56

7D

1.4%

1Y

-15.2%

Corcept Therapeutics

Market Cap: US$7.8b

Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

CORT

US$69.31

7D

-9.7%

1Y

119.6%

Roivant Sciences

Market Cap: US$7.7b

A clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies.

ROIV

US$10.94

7D

-5.2%

1Y

3.6%

Revolution Medicines

Market Cap: US$6.9b

A clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers.

RVMD

US$36.89

7D

-7.8%

1Y

-1.3%

Legend Biotech

Market Cap: US$6.5b

Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.

LEGN

US$36.29

7D

5.8%

1Y

-18.9%

ZEEKR Intelligent Technology Holding

Market Cap: US$6.5b

An investment holding company, engages in the research and development, production, commercialization, and sale of the electric vehicles and batteries.

ZK

US$25.64

7D

-3.2%

1Y

42.4%

Jazz Pharmaceuticals

Market Cap: US$6.4b

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.

JAZZ

US$109.44

7D

1.2%

1Y

4.1%

Lantheus Holdings

Market Cap: US$5.7b

Develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide.

LNTH

US$79.42

7D

-1.9%

1Y

1.2%

Nuvalent

Market Cap: US$5.5b

A clinical-stage biopharmaceutical company, engages in the development of therapies for patients with cancer.

NUVL

US$78.01

7D

1.5%

1Y

6.9%

Axsome Therapeutics

Market Cap: US$5.2b

A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.

AXSM

US$102.97

7D

-1.2%

1Y

30.5%

Chagee Holdings

Market Cap: US$4.8b

Through its subsidiaries, owns, operates, and franchises teahouses under the CHAGEE brand name in the People’s Republic of China and internationally.

CHA

US$26.20

7D

-6.9%

1Y

n/a

ChampionX

Market Cap: US$4.8b

Provides chemistry solutions, artificial lift systems, and engineered equipment and technologies to oil and gas companies worldwide.

CHX

US$25.92

7D

5.1%

1Y

-21.5%

Pony AI

Market Cap: US$4.7b

Through its subsidiaries, engages in the autonomous mobility business in the People’s Republic of China, the United States, and internationally.

PONY

US$13.20

7D

-0.5%

1Y

n/a

CRISPR Therapeutics

Market Cap: US$4.5b

A gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform.

CRSP

US$48.51

7D

3.7%

1Y

-8.7%

ADMA Biologics

Market Cap: US$4.3b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

ADMA

US$17.88

7D

0.2%

1Y

56.8%

Vaxcyte

Market Cap: US$4.2b

A clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.

PCVX

US$32.94

7D

-3.4%

1Y

-56.7%

Cytokinetics

Market Cap: US$3.9b

A late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases in the United States.

CYTK

US$33.64

7D

0.7%

1Y

-38.7%

Merus

Market Cap: US$3.9b

A clinical-stage immuno-oncology company, engages in the development of antibody therapeutics in the Netherlands.

MRUS

US$52.66

7D

-2.7%

1Y

-0.8%

Zai Lab

Market Cap: US$3.9b

A biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.

ZLAB

US$35.17

7D

-6.4%

1Y

102.5%

Cellebrite DI

Market Cap: US$3.8b

Develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific.

CLBT

US$15.81

7D

-2.8%

1Y

30.4%

Inspire Medical Systems

Market Cap: US$3.8b

A medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally.

INSP

US$130.81

7D

-1.3%

1Y

-2.6%

Remitly Global

Market Cap: US$3.8b

Engages in the provision of digital financial services in the United States, Canada, and internationally.

RELY

US$18.46

7D

-9.3%

1Y

48.3%

Core Natural Resources

Market Cap: US$3.7b

Produces, sells, and exports metallurgical and thermal coals in the United States and internationally.

CNR

US$65.27

7D

-4.2%

1Y

-36.8%

Zeta Global Holdings

Market Cap: US$3.6b

Operates an omnichannel data-driven cloud platform that provides enterprises with consumer intelligence and marketing automation software in the United States and internationally.

ZETA

US$15.14

7D

-6.1%

1Y

-13.2%

Arcellx

Market Cap: US$3.6b

Together with its subsidiary, engages in the development of various immunotherapies for patients with cancer and other incurable diseases in the United States.

ACLX

US$64.69

7D

2.1%

1Y

21.5%

Ultragenyx Pharmaceutical

Market Cap: US$3.4b

A biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Europe, the Middle East, Africa, and the Asia-Pacific.

RARE

US$36.26

7D

-2.4%

1Y

-11.5%

Avidity Biosciences

Market Cap: US$3.4b

A biopharmaceutical company, engages in the delivery of RNA therapeutics called antibody oligonucleotide conjugates (AOCs).

RNA

US$28.46

7D

-4.7%

1Y

-26.6%

GEO Group

Market Cap: US$3.3b

Owns, leases, operates, and manages secure facilities, processing centers, and community-based reentry facilities in the United States, Australia, the United Kingdom, and South Africa.

GEO

US$24.49

7D

5.2%

1Y

60.2%

Freshpet

Market Cap: US$3.3b

Manufactures, distributes, and markets natural fresh meals and treats for dogs and cats in the United States, Canada, and Europe.

FRPT

US$71.28

7D

-1.3%

1Y

-46.1%

Braze

Market Cap: US$3.1b

Operates a customer engagement platform that provides interactions between consumers and brands worldwide.

BRZE

US$28.17

7D

5.2%

1Y

-28.6%

Page 1 of 33